Premium
Colchicine may be of therapeutic benefit in prurigo pigmentosa
Author(s) -
An Isa,
Ucmak Derya,
Ibiloglu Ibrahim,
Demir Vasfiye,
Akdeniz Sedat
Publication year - 2018
Publication title -
pediatric dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 73
eISSN - 1525-1470
pISSN - 0736-8046
DOI - 10.1111/pde.13480
Subject(s) - colchicine , medicine , inflammation , chemotaxis , dermatology , immunology , pharmacology , receptor
Prurigo pigmentosa (PP) is a rare inflammatory skin disease. Neutrophil‐mediated inflammation is considered to be responsible for the etiopathogenesis of PP. We consider that colchicine may be an effective agent in the treatment of PP since it exerts an antiinflammatory effect by inhibiting neutrophil chemotaxis. Further studies are required to verify whether colchicine is an effective treatment option for PP.